Scholarlink

<p>Optical manipulation of proteins is central to probing and engineering cellular functions. However, existing optogenetic tools based on natural photoreceptors and chemo-optogenetic tools based on natural protein–ligand pairs are difficult to reconfigure for the desired photochemical and binding properties. Here we introduce a de novo approach for creating chemo-optogenetic tools. Instead of modifying pre-existing ligands, we first design a synthetic photoswitch with defined properties and then use mRNA display to select for artificial protein binders that recognize a specific photoisomer-dependent conformation. This bottom-up framework yields artificial photoswitch–protein binder pairs that enable precise optical control of diverse biological activities in mammalian cells, such as kinase and lipid signalling, G-protein-coupled receptor activation, gene expression and cell differentiation. The regulatory mode (sustained, reversible or repeatable) is readily programmed by adjusting light inputs. This de novo approach provides customizable synthetic photoswitch–protein binder pairs, expanding opportunities for optical protein manipulation in biological and biomedical applications.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

De novo chemo-optogenetics through the rational design of photoresponsive molecules and selection of their artificial protein binding pairs

  • 期刊论文

  • 发表日期：

    2026年4月23日

查看全文
  • Tomoki Miyazaki,
  • Tomoshige Fujino,
  • Tatsuyuki Yoshii,
  • Haruto Kosugi,
  • Mamoru Funane,
  • Naoya Murata,
  • Kim Chung Nguyen,
  • Satoru Nagatoishi,
  • Kouhei Tsumoto,
  • Gosuke Hayashi,
  • Hiroshi Murakami,
  • Shinya Tsukiji

摘要

Optical manipulation of proteins is central to probing and engineering cellular functions. However, existing optogenetic tools based on natural photoreceptors and chemo-optogenetic tools based on natural protein–ligand pairs are difficult to reconfigure for the desired photochemical and binding properties. Here we introduce a de novo approach for creating chemo-optogenetic tools. Instead of modifying pre-existing ligands, we first design a synthetic photoswitch with defined properties and then use mRNA display to select for artificial protein binders that recognize a specific photoisomer-dependent conformation. This bottom-up framework yields artificial photoswitch–protein binder pairs that enable precise optical control of diverse biological activities in mammalian cells, such as kinase and lipid signalling, G-protein-coupled receptor activation, gene expression and cell differentiation. The regulatory mode (sustained, reversible or repeatable) is readily programmed by adjusting light inputs. This de novo approach provides customizable synthetic photoswitch–protein binder pairs, expanding opportunities for optical protein manipulation in biological and biomedical applications.